The Guidant Legacy: An Interview with Ron Dollens

Guidant emerged as one of the important device companies, all but creating the interventional cardiology business and playing a major role in the evolution of cardiac rhythm management. One person stood behind all of these accomplishments and guided Guidant virtually to its end: Ron Dollens, who retired as CEO last year just before the sale of the company to Boston Scientific was made final. Dollens talks about his career at Eli Lilly and Guidant and about his-and Guidant's-final days.